Summary statements on prognostic factors in carcinoma of the uterine cervix

CME Journal of Gynecologic Oncology

Volumn 8, Issue 3, 2003, Pages 233-236

  Syrjänen, Kari ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Cervical carcinoma; Prognostic factors; Summary statements

Indexed keywords

PROTEIN E6; PROTEIN E7;

CANCER STAGING; FEMALE; HUMAN; LAPAROSCOPIC SURGERY; LAPAROSCOPICALLY ASSISTED VAGINAL RADICAL HYSTERECTOMY; PROGNOSIS; REVIEW; UTERINE CERVIX CARCINOMA; WART VIRUS;

EID: 1442314293     PISSN: 12199087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Bösze P, Bast RC, Berchuck A, Burke HB, Buller RE, Creasman WT, Dubeau L, Fox H, Geisler HE, Geisler JP, Henson DE, Rustin GJ, Vermorken JB, Wells M, Wilbanks GD. Consensus statements on prognostic factors in epithelial ovarian carcinoma. Report of the Consensus Meeting organized by the European Society of Gynaecological Oncology, ESGO. Eur J Gynaecol Oncol. 2000; 21:513-526.
2. Bösze P. Editor's introduction. CME J Gynecol Oncol 2001; 6:75.
3. Duarte-Franco E, Franco E. Determinants of patient survival in cervical cancer: an overview. CME J Gynecol Oncol 2001; 6:173-183.
4. Winter R, Haas J, Reich O, Lahousen M, Tamussino K. Prognostic significance of parametrial involvement in cervical cancer. CME J Gynecol Oncol 2001; 6:204-208.
5. Magrina JF. The prognostic significance of pelvic and para-aortic lymph node metastasis. CME J Gynecol Oncol 2001; 6:302-306.
6. Boyd SC, Look KY. Prognostic factors for carcinoma of the cervical stump and for cervical carcinoma associated with pregnancy. CME J Gynecol Oncol 2001; 6: 347-356.
7. Fotiou SK. Carcinoma of the uterine cervix-prognostic implications of the mode of therapy and quality of life. CME J Gynecol Oncol 2001; 6:385-390.
8. Burger CW, Baalbergen A, Helmerhorst T. Prognostic factors that predict survival after relapse of cervical cancer. CME J Gynecol Oncol 2001; 6:391-397.
9. Takeshima N. The prognostic significance of the serum squamous cell carcinoma antigen (SCCA) levels and other serum markers, including hormones such as prolactin, etc. In cervical carcinoma. CME J Gynecol Oncol 2001; 6:76-80.
10. Geisler JP, Geisler HE, Miller GA, Wiemann MC, Zhou Z, Miller J, Crabtree W. Serum and molecular biological markers in cervical carcinomma and carcinoma in situ. CME J Gynecol Oncol 2001; 6:81-85.
11. Coimbra HA, Regateiro FJ. Genetics of hereditary cervical cancer. CME J Gynecol Oncol 2001; 6:371-376.
12. Benitez J, Cigudosa JC. Prognostic significance of chromosome abnormalities, X chromosome inactivation, and loss of heterozigosity in cervical cancer. CME J Gynecol Oncol. 2003; 8:282-286.
13. Goff BA, Paley PJ. Prognostic significance of preirradiation surgical staging and adjuvant hysteterctomy in carcinoma of the cervix. CME J Gynecol Oncol 2001; 6: 86-91.
14. Dargent D, Martin X, Mathevet P. Prognostic factors in patients managed by laparoscopically assisted vaginal radical hysterectomy (LAVRH) for early cervical cancer. Indications for LAVRH facing the different prognostic factors. CME J Gynecol Oncol. 2003; 8:000-000
15. Kleinberg MJ, Straughn JM, Alvarez RD. Concurrent chemotherapy and radiation for advanced cervical cancer. CME J Gynecol Oncol 2001; 6:92-98.
16. Smit BJ. Adjuvant pre- and postoperative radiation therapy, influence on negative prognostic factors-review of the recent literature. CME J Gynecol Oncol 2001; 6:209-215.
17. Duval PJ. Prognostic significance of radiation technique and prognostic factors for primary radiotherapy. CME J Gynecol Oncol 2001; 6:357-363.
18. Van der Zee J, Gonzalez DG, van Rhoon GC, van Dijk JPD, van Putten WLJ, Hart AAM. Hyperthermia combined with radiotherapy: prognostic significance. CME J Gynecol Oncol 2001; 6:364-370.
19. Huh WK, Alvarez RD, Curiel DT. Gene therapy and cervical cancer: an overview. CME J Gynecol Oncol 2001; 6:377-382.
20. Shin B, Dubeau L. Cell cycle abnormalities in squamous cell carcinoma of the cervix. CME J Gynecol Oncol 2001; 6:167-172.
21. Obermair A, Preyer O, Bactiary B. Angiogenesis in cervical carcinoma. CME J Gynecol Oncol 2001; 6:184-191.
22. Kristensen GB, Tropé C. Evaluation of the prognostic significance of DNA ploidy and S-phase fraction in cancer of the uterine cervix. CME J Gynecol Oncol 2001; 6: 192-195.
23. Kristensen GB, Tropé C. Modern prognostic factors in cervical cancer with special attention to early disease. CME J Gynecol Oncol 2001; 6:196-203.
24. Höckel M, Vaupel P. Prognostic significance of tissue hypoxia in cervical cancer. CME J Gynecol Oncol 2001; 6:216-225.
25. Syrjänen KJ, Erzen M, Costa S. Histological and quantitative pathological prognostic factors in cervical cancer. CME J Gynecol Oncol 2001; 6:279-301.
26. Erzen M, Rakar S. Prognostic factors in microinvasive cervical carcinoma. CME J Gynecol Oncol 2001; 6:307-323.
27. Syrjänen K, Erzen M. The prognostic significance of human papillomavirus (HPV) infections and cancer screening. CME J Gynecol Oncol 2001; 6:325-346.
28. Kohlberger P, Gitsch G. Immunology of cervical cancer. CME J Gynecol Oncol 2001; 6:383-384.
29. von Knebel-Doeberitz M. Prognostic significance of p16INK4a expression and integrated human papillomavirus oncogene transcripts in dysplastic lesions of the uterine cervix. CME J Gynecol Oncol. 2003; 8:000-000.